
Pyrazinamide (400mg) + Isoniazid (75mg) + Rifampicin (150mg) + Ethambutol (275mg)
Active composition
+3 more active ingredients
Pyrazinamide inhibits the synthesis of mycolic acids in the bacterial cell wall, leading to cell death in Mycobacterium tuberculosis.
Isoniazid inhibits the enzyme responsible for mycolic acid synthesis, disrupting bacterial cell wall formation and leading to cell death.
Rifampicin inhibits bacterial RNA polymerase, preventing transcription and leading to bacterial cell death.
Medical applications
Mycurit 4 mg Tablet is a combined anti-tuberculosis medication containing Isoniazid 75mg, Rifampicin 150mg, Ethambutol 275mg, and Pyrazinamide 400mg. This fixed-dose combination is prescribed for the treatment of active tuberculosis and latent tuberculosis infection. Isoniazid inhibits mycolic acid synthesis, Rifampicin interferes with bacterial DNA-dependent RNA polymerase, Ethambutol inhibits mycolic acid arabinopyranosyl transferase, and Pyrazinamide functions as a bacteriostatic and bactericidal agent. The synergistic action of these drugs enhances the efficacy and reduces the risk of drug resistance. It is essential to follow a complete treatment course as prescribed to ensure successful treatment and prevent relapse. Consult your healthcare provider for any potential drug interactions or side effects.
How to use Mycurit Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mycurit 4 mg Tablet is to be taken empty stomach. Avoid Mycurit 4 mg Tablet with tyramine-rich food such as cheese, smoked fish, meats and some types of beer.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Consuming alcohol while taking Mycurit 4 mg Tablet may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
High Risk
Mycurit 4 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Mycurit 4 mg Tablet may cause side effects which could affect your ability to drive. Mycurit 4 mg Tablet occasionally causes sight problems and tingling or numbness in hand or feet. After taking this medicine you should not drive until you know how it affects you.
Exercise Caution
Mycurit 4 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Mycurit 4 mg Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is advised before and after the start of the treatment.
Regular Checkup
Mycurit 4 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Consult Doctor
Mycurit 4 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mycurit 4 mg Tablet may be needed. Please consult your doctor. Kidney function tests are advisable before the start of this medicine.
Regular Checkup
0 reviews for Mycurit 4 mg Tablet

Isoniazid (75mg) + Rifampicin (150mg) + Ethambutol (275mg) + Pyrazinamide (400mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+3 more active ingredients
Pyrazinamide inhibits the synthesis of mycolic acids in the bacterial cell wall, leading to cell death in Mycobacterium tuberculosis.
Isoniazid inhibits the enzyme responsible for mycolic acid synthesis, disrupting bacterial cell wall formation and leading to cell death.
Rifampicin inhibits bacterial RNA polymerase, preventing transcription and leading to bacterial cell death.
Medical applications
Mycurit 4 mg Tablet is a combined anti-tuberculosis medication containing Isoniazid 75mg, Rifampicin 150mg, Ethambutol 275mg, and Pyrazinamide 400mg. This fixed-dose combination is prescribed for the treatment of active tuberculosis and latent tuberculosis infection. Isoniazid inhibits mycolic acid synthesis, Rifampicin interferes with bacterial DNA-dependent RNA polymerase, Ethambutol inhibits mycolic acid arabinopyranosyl transferase, and Pyrazinamide functions as a bacteriostatic and bactericidal agent. The synergistic action of these drugs enhances the efficacy and reduces the risk of drug resistance. It is essential to follow a complete treatment course as prescribed to ensure successful treatment and prevent relapse. Consult your healthcare provider for any potential drug interactions or side effects.
How to use Mycurit Tablet Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Mycurit 4 mg Tablet is to be taken empty stomach. Avoid Mycurit 4 mg Tablet with tyramine-rich food such as cheese, smoked fish, meats and some types of beer.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Consuming alcohol while taking Mycurit 4 mg Tablet may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
High Risk
Mycurit 4 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Mycurit 4 mg Tablet may cause side effects which could affect your ability to drive. Mycurit 4 mg Tablet occasionally causes sight problems and tingling or numbness in hand or feet. After taking this medicine you should not drive until you know how it affects you.
Exercise Caution
Mycurit 4 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Mycurit 4 mg Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is advised before and after the start of the treatment.
Regular Checkup
Mycurit 4 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Consult Doctor
Mycurit 4 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Mycurit 4 mg Tablet may be needed. Please consult your doctor. Kidney function tests are advisable before the start of this medicine.
Regular Checkup
0 reviews for Mycurit 4 mg Tablet















